Skip to main content
. 2020 Oct 19;12(10):3038. doi: 10.3390/cancers12103038
AJCC American Joint Committee on Cancer
DFS disease-free survival
DSS disease-specific survival
ER estrogen receptor
FDR false discovery rate
HER2 human epidermal growth factor receptor 2
NES normalized enrichment score
OS overall survival
pCR pathological complete response
TCGA The Cancer Genome Atlas
TNBC triple negative breast cancer